Ironwood Pharmaceuticals, Inc., a commercial biotechnology company, engages in the research, development, and commercialization of human therapeutic products. The company markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZESS name in the United States and CONSTELLA […]
Read MoreConcerns about a slowing global economy have persisted for a number of months now, and while U.S. stocks have risen nicely through most of the year, in the last month or so their rally from a pre-Christmas low has seemingly been capped by persistent concerns about the slowing global economy. Indeed, it seems that the […]
Read More